ProPhase Labs, Inc.
PRPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000868278
No open-market purchases or sales by ProPhase Labs, Inc. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $2 in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in ProPhase Labs, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- −4 vs. Q2 2025
- Shares held
- 2.98M
- +302.6K (+11.3%) vs. Q2 2025
- Total value
- $1.36M
- +$316.5K (+30.2%) vs. Q2 2025
- New holders
- 6
- 6 more added
- Sold out
- 10
- 5 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $2 |
| Q1 2026 | 2 | $2 |
| Q4 2025 | 17 | $92.9K |
| Q3 2025 | 29 | $1.36M |
| Q2 2025 | 33 | $1.05M |
| Q1 2025 | 37 | $2.02M |
| Q4 2024 | 30 | $1.91M |
| Q3 2024 | 27 | $4.23M |
| Q2 2024 | 29 | $7.27M |
| Q1 2024 | 32 | $11.0M |
| Q4 2023 | 27 | $7.63M |
| Q3 2023 | 35 | $8.56M |
| Q2 2023 | 45 | $15.8M |
| Q1 2023 | 39 | $18.6M |
| Q4 2022 | 51 | $26.7M |
| Q3 2022 | 43 | $30.3M |
| Q2 2022 | 39 | $24.9M |
| Q1 2022 | 22 | $10.8M |
| Q4 2021 | 25 | $10.8M |
| Q3 2021 | 21 | $8.56M |
| Q2 2021 | 23 | $9.95M |
| Q1 2021 | 29 | $9.58M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding ProPhase Labs, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sykon Capital LLC | 644,795 | $295.2K | 0.10% | 00.0% | Unchanged |
| Vanguard Group Inc | 531,919 | $243.6K | 0.00% | +123,652+30.3% | Added |
| Susquehanna International Group, LLP | 397,914 | $182.2K | 0.00% | +295,899+290.1% | Added |
| Geode Capital Management, LLC | 302,929 | $138.7K | 0.00% | +43,866+16.9% | Added |
| Accretive Wealth Partners, LLC | 250,000 | $114.5K | 0.03% | +250,000 | New |
| HighTower Advisors, LLC | 237,338 | $108.7K | 0.00% | +7,884+3.4% | Added |
| Apollon Wealth Management, LLC | 182,464 | $83.5K | 0.00% | +182,464 | New |
| Chapin Davis, Inc. | 80,000 | $36.6K | 0.01% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 47,472 | $21.7K | 0.00% | +9,643+25.5% | Added |
| State Street Corp | 44,663 | $20.4K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 40,598 | $18.0K | 0.00% | +28,984+249.6% | Added |
| Bank of New York Mellon Corp | 37,052 | $17.0K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 28,768 | $13.2K | 0.00% | −73,738−71.9% | Reduced |
| BlackRock, Inc. | 28,026 | $12.8K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 23,214 | $10.6K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 19,740 | $9.04K | 0.00% | −37,930−65.8% | Reduced |
| BKD Wealth Advisors, LLC | 19,598 | $8.97K | 0.00% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 14,795 | $7.00K | 0.00% | +14,795 | New |
| Annex Advisory Services, LLC | 15,000 | $6.87K | 0.00% | +15,000 | New |
| Renaissance Technologies LLC | 10,100 | $4.62K | 0.00% | −127,823−92.7% | Reduced |
| Nordwand Advisors, LLC | 10,000 | $4.58K | 0.00% | +10,000 | New |
| Morgan Stanley | 9,167 | $4.20K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,765 | $808 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,530 | $700 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,118 | $511 | 0.00% | −26,071−95.9% | Reduced |
| SBI Securities Co., Ltd. | 504 | $231 | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 100 | $46 | 0.00% | −3,400−97.1% | Reduced |
| Farther Finance Advisors, LLC | 97 | $44 | 0.00% | 00.0% | Unchanged |
| Key Financial Inc | 1 | $1 | 0.00% | +1 | New |
| Quinn Opportunity Partners LLC | 0 | $0 | 0.00% | −218,127−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −59,468−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −40,401−100.0% | Sold out |
| United Capital Management of KS, Inc. | 0 | $0 | 0.00% | −34,700−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −19,000−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −16,858−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −11,767−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −198−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |